Targeting Ovarian Cancer with IL-2 Cytokine/Antibody Complexes: A Summary and Recent Advances

Yilun Deng1, Ryan M Reyes2,3, Chenghao Zhang1,4, José Conejo-Garcia5, Tyler J. Curiel1,2,3,6* 1Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA 2South Texas Medical Scientist Training Program, University of Texas Health San Antonio, San Antonio, TX, USA 3Mays Family Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA 4Xiangya Medical School, Central South University, Changsha, Hunan, China 5H. Lee Moffitt Cancer Research Institute, Department of Immunology, Tampa, FL, USA 6Graduate School of Biomedical Sciences, University of Texas Health San Antonio, San Antonio, TX, USA